| Group Health Cooperative Home & Community Services 201 - 16th Avenue East, Seattle, WA, 98112 | |
| (206) 326-4545 |
News Archive
To get a better look at the abnormalities that cause age-related macular degeneration (AMD), the leading cause of vision loss in Americans and Europeans over 50, the research groups of James Fujimoto at the Massachusetts Institute of Technology (MIT) and collaborators Jay Duker of the Tufts University School of Medicine, and Joel Schuman of the University of Pittsburgh School of Medicine have created ultra-detailed 3-D images of the eyes of more than 2,000 people from different ethnic groups, 400 of whom have AMD.
While slightly less than half of those polled by the Wall Street Journal and NBC think the law is a bad idea, only 21 percent want it repealed.
Inhibitex, Inc. today announced its financial results for the second quarter ended June 30, 2010.
Researchers at the David Geffen School of Medicine at UCLA and the University of Texas Medical Branch at Galveston have discovered a molecular process by which the body can defend against the effects of Clostridium difficile infection (CDI), pointing the way to a promising new approach for treating an intestinal disease that has become more common, more severe and harder to cure in recent years.
› Verified 3 days ago
| Name | Group Health Cooperative Home & Community Services |
|---|---|
| Location | 201 - 16th Avenue East, Seattle, Washington |
| Hospice ID | 501521 |
| Category | Freestanding Hospice |
| Ownership Type | Other |
| Profit Type | OTHER |
| SSA county code | 160 |
News Archive
To get a better look at the abnormalities that cause age-related macular degeneration (AMD), the leading cause of vision loss in Americans and Europeans over 50, the research groups of James Fujimoto at the Massachusetts Institute of Technology (MIT) and collaborators Jay Duker of the Tufts University School of Medicine, and Joel Schuman of the University of Pittsburgh School of Medicine have created ultra-detailed 3-D images of the eyes of more than 2,000 people from different ethnic groups, 400 of whom have AMD.
While slightly less than half of those polled by the Wall Street Journal and NBC think the law is a bad idea, only 21 percent want it repealed.
Inhibitex, Inc. today announced its financial results for the second quarter ended June 30, 2010.
Researchers at the David Geffen School of Medicine at UCLA and the University of Texas Medical Branch at Galveston have discovered a molecular process by which the body can defend against the effects of Clostridium difficile infection (CDI), pointing the way to a promising new approach for treating an intestinal disease that has become more common, more severe and harder to cure in recent years.
› Verified 3 days ago
| NPI Number | 1437289576 |
| Organization Name | Kaiser Foundation Health Plan Of Washington |
| Address | 201 16th Ave E Seattle, Washington, 98112 |
| Phone Number | (206)326-4530 |
News Archive
To get a better look at the abnormalities that cause age-related macular degeneration (AMD), the leading cause of vision loss in Americans and Europeans over 50, the research groups of James Fujimoto at the Massachusetts Institute of Technology (MIT) and collaborators Jay Duker of the Tufts University School of Medicine, and Joel Schuman of the University of Pittsburgh School of Medicine have created ultra-detailed 3-D images of the eyes of more than 2,000 people from different ethnic groups, 400 of whom have AMD.
While slightly less than half of those polled by the Wall Street Journal and NBC think the law is a bad idea, only 21 percent want it repealed.
Inhibitex, Inc. today announced its financial results for the second quarter ended June 30, 2010.
Researchers at the David Geffen School of Medicine at UCLA and the University of Texas Medical Branch at Galveston have discovered a molecular process by which the body can defend against the effects of Clostridium difficile infection (CDI), pointing the way to a promising new approach for treating an intestinal disease that has become more common, more severe and harder to cure in recent years.
› Verified 3 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.3 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 98.7 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.2 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 91.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.6 | 97.3 |
| Patients who got timely treatment for shortness of breath | 97.5 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 95.0 | 93.3 |
News Archive
To get a better look at the abnormalities that cause age-related macular degeneration (AMD), the leading cause of vision loss in Americans and Europeans over 50, the research groups of James Fujimoto at the Massachusetts Institute of Technology (MIT) and collaborators Jay Duker of the Tufts University School of Medicine, and Joel Schuman of the University of Pittsburgh School of Medicine have created ultra-detailed 3-D images of the eyes of more than 2,000 people from different ethnic groups, 400 of whom have AMD.
While slightly less than half of those polled by the Wall Street Journal and NBC think the law is a bad idea, only 21 percent want it repealed.
Inhibitex, Inc. today announced its financial results for the second quarter ended June 30, 2010.
Researchers at the David Geffen School of Medicine at UCLA and the University of Texas Medical Branch at Galveston have discovered a molecular process by which the body can defend against the effects of Clostridium difficile infection (CDI), pointing the way to a promising new approach for treating an intestinal disease that has become more common, more severe and harder to cure in recent years.
› Verified 3 days ago
| Home Health Aides | 10.35 |
| Counselors | 7.05 |
| Medical Social Workers | 14.76 |
| Physicians | 4.45 |
| Registered Nurses | 41.11 |
| Other Personnel | 4.66 |
| Total Employees | 82.38 |
|---|
News Archive
To get a better look at the abnormalities that cause age-related macular degeneration (AMD), the leading cause of vision loss in Americans and Europeans over 50, the research groups of James Fujimoto at the Massachusetts Institute of Technology (MIT) and collaborators Jay Duker of the Tufts University School of Medicine, and Joel Schuman of the University of Pittsburgh School of Medicine have created ultra-detailed 3-D images of the eyes of more than 2,000 people from different ethnic groups, 400 of whom have AMD.
While slightly less than half of those polled by the Wall Street Journal and NBC think the law is a bad idea, only 21 percent want it repealed.
Inhibitex, Inc. today announced its financial results for the second quarter ended June 30, 2010.
Researchers at the David Geffen School of Medicine at UCLA and the University of Texas Medical Branch at Galveston have discovered a molecular process by which the body can defend against the effects of Clostridium difficile infection (CDI), pointing the way to a promising new approach for treating an intestinal disease that has become more common, more severe and harder to cure in recent years.
› Verified 3 days ago
| Others | 1.6 |
| Total Volunteers | 1.6 |
|---|
News Archive
To get a better look at the abnormalities that cause age-related macular degeneration (AMD), the leading cause of vision loss in Americans and Europeans over 50, the research groups of James Fujimoto at the Massachusetts Institute of Technology (MIT) and collaborators Jay Duker of the Tufts University School of Medicine, and Joel Schuman of the University of Pittsburgh School of Medicine have created ultra-detailed 3-D images of the eyes of more than 2,000 people from different ethnic groups, 400 of whom have AMD.
While slightly less than half of those polled by the Wall Street Journal and NBC think the law is a bad idea, only 21 percent want it repealed.
Inhibitex, Inc. today announced its financial results for the second quarter ended June 30, 2010.
Researchers at the David Geffen School of Medicine at UCLA and the University of Texas Medical Branch at Galveston have discovered a molecular process by which the body can defend against the effects of Clostridium difficile infection (CDI), pointing the way to a promising new approach for treating an intestinal disease that has become more common, more severe and harder to cure in recent years.
› Verified 3 days ago
| Providence Hospice Of Seattle Location: 425 Pontius Avenue North, #300, Seattle, Washington, 98109 Phone: (206) 326-4545 |
| Group Health Cooperative Home & Community Services Location: 201 - 16th Avenue East, Seattle, Washington, 98112 Phone: (206) 326-4545 |
| Kline Galland Hospice Services Location: 5950 Sixth Ave S Suite 100, Seattle, Washington, 98108 Phone: (206) 326-4545 |
| Kindred Hospice Location: 115 Ne 100th St Bldg A Suite 210, Seattle, Washington, 98125 Phone: (206) 326-4545 |